Design, Synthesis, and Structure—Activity Relationships of a Series of 2-Ar-8-methyl-5-alkylaminoquinolines as Novel CRF1 Receptor Antagonists.
2013
Novel compounds (VI) are identified as orally active corticotropin-releasing factor 1 (CRF1) receptor antagonists.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
1
References
0
Citations
NaN
KQI